Form 4: Integrated BioPharma Director Acquires 50,000 Stock Options
SEC Form 4 Filing
Robert Canarick, a director of Integrated BioPharma, Inc., acquired 50,000 stock options on August 7, 2024, exercisable at $0.18.
Summary
- On August 7, 2024, Robert Canarick, a director at Integrated BioPharma, Inc. (INBP), acquired 50,000 stock options.
- The exercise price for these options is $0.18 per share.
- The options vest in four equal installments of 12,500 each on September 30, 2024, December 31, 2024, March 31, 2025, and June 30, 2025.
- The expiration date for these options is August 7, 2034.
- Following the transaction, Canarick directly owns 50,000 derivative securities.
Sentiment
Score: 5
Explanation: The document is a neutral regulatory filing, indicating a standard transaction. It doesn't inherently convey positive or negative sentiment.
Industry Context
This filing is a routine disclosure of insider transactions, which are common in the biopharmaceutical industry as part of executive compensation packages.
Stakeholder Impact
- The acquisition of stock options by a director could be perceived positively by shareholders as it aligns the director's interests with the company's performance.
Key Dates
| Date | Description |
|---|---|
| 08/07/2024 | Date of transaction: Robert Canarick acquired 50,000 stock options. |
| 09/30/2024 | First vesting date: 12,500 stock options vest. |
| 12/31/2024 | Second vesting date: 12,500 stock options vest. |
| 03/31/2025 | Third vesting date: 12,500 stock options vest. |
| 06/30/2025 | Fourth vesting date: 12,500 stock options vest. |
| 08/07/2034 | Expiration date of the stock options. |
| 08/08/2024 | Date of signature. |
Keywords
stock options, Form 4, director, INBP, Integrated BioPharma, beneficial ownership, Robert Canarick
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.